- Announces $200 Million Share Repurchase Program
- Declares Second Quarter Dividend of $0.12/share
- Provides Final Results of Tender Offer
Horizon Pharma is a 'giant headache,' says Jim Cramer; Abbot Labs is OK long term.
Holiday-shortened week holds a feast of earnings reports, says Jim Cramer.
Stocks are mixed Thursday after Federal Reserve Chair Janet Yellen says that an interest rate hike could come soon.